Key facts
- It has raised $29.2M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Qiming Venture Partners, Tailong VC, Aedlus Capital, Hangzhou Tigermed Consulting Company, Mabwell — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Slanhealth
- ·The full record, as it builds
Funding rounds
No funding rounds for Slanhealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Slanhealth
Developer of post-doctor's visit health management software designed to improve the efficiency and risk control of medical programs. The company's mobile app helps medical professionals continue care with post-operative and post-natal patients through follow up communication and education, enabling medical industry users with digital medical solutions and products.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2015
- Employees
- 36
- Website
- vongihealth.com/
- Ownership
- Privately Held (backing)
Slanhealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Slanhealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Slanhealth in its N-PORT filings yet. We sweep new filings monthly.